Literature DB >> 22543997

Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature.

Abhijeet Ghatol1, A Parker Ruhl, Sonye K Danoff.   

Abstract

BACKGROUND: Acute exacerbations (AE) of idiopathic pulmonary fibrosis (IPF) are well recognized in the progression of this uniformly fatal disease. Surgical lung biopsy and lung resection may initiate these acute events leading to a rapid deterioration and permanent decline in lung function. Our aim is to discuss the role of pulmonary and nonpulmonary surgery as a precipitating factor and to review the literature on the nature, course, and outcomes of acute exacerbations in the context of surgical interventions.
METHODS: This study consisted of a retrospective case series of patients at the Johns Hopkins Hospital who experienced acute exacerbation following a surgical procedure. Patients included in the case series suffered from aggravation of dyspnea within 1 month after surgical intervention, with new infiltrates on imaging. There was no other more likely cause after diagnostic evaluation. A comprehensive review of the current literature pertaining to AEs of IPF in the context of a surgical intervention was performed.
RESULTS: In a series of four patients from Johns Hopkins Hospital with AE in IPF, two of three patients who underwent video-assisted thoracoscopic surgery (VATS) lung biopsy had a fatal outcome. The fourth patient survived an AE after a total knee replacement but had a fatal outcome after a subsequent coronary artery bypass graft surgery. We found no report in the literature of AE in an IPF patient who underwent nonpulmonary surgery.
CONCLUSIONS: Acute exacerbations of IPF can occur postoperatively after both pulmonary and nonpulmonary surgery and are associated with a high mortality rate. As a next step, a prospective multicenter clinical study of patients with IPF undergoing both pulmonary and nonpulmonary surgeries would allow the identification of perioperative risk factors in the development of AE of IPF.

Entities:  

Mesh:

Year:  2012        PMID: 22543997     DOI: 10.1007/s00408-012-9389-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  26 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Fahad M Al-Hameed; Sat Sharma
Journal:  Can Respir J       Date:  2004-03       Impact factor: 2.409

3.  Outcomes and safety of surgical lung biopsy for interstitial lung disease.

Authors:  Christopher J Lettieri; Ganesh R Veerappan; Donald L Helman; Charles R Mulligan; Andrew F Shorr
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

4.  Anticoagulant therapy for idiopathic pulmonary fibrosis.

Authors:  Hiroshi Kubo; Katsutoshi Nakayama; Masaru Yanai; Tomoko Suzuki; Mutsuo Yamaya; Mika Watanabe; Hidetada Sasaki
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

5.  Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia.

Authors:  Leena Tiitto; Ulla Heiskanen; Risto Bloigu; Paavo Pääkkö; Vuokko Kinnula; Riitta Kaarteenaho-Wiik
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

6.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 7.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

8.  Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.

Authors:  Matthias Schmidt; Guo Sun; Martin A Stacey; Luca Mori; Sabrina Mattoli
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.

Authors:  Hidenori Kawasaki; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Yutaka Nishiwaki
Journal:  J Surg Oncol       Date:  2002-09       Impact factor: 3.454

10.  Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study.

Authors:  Martin I Sigurdsson; Helgi J Isaksson; Gunnar Gudmundsson; Tomas Gudbjartsson
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

View more
  29 in total

1.  Non-specific and Usual Interstitial Pneumonia, Short-Term Survival After Surgical Biopsy.

Authors:  Barbara J Knipscheer; Coline H M van Moorsel; Jan C Grutters
Journal:  Lung       Date:  2015-04-02       Impact factor: 2.584

2.  Acute exacerbation of idiopathic interstitial pneumonia after nonpulmonary surgery under general anesthesia: a retrospective study.

Authors:  Kenta Furuya; Susumu Sakamoto; Yujiro Takai; Nobukazu Sato; Keiko Matsumoto; Sakae Homma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 3.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

4.  Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis.

Authors:  Seok Joo; Dong Kwan Kim; Hee Je Sim; Geun Dong Lee; Su Kyung Hwang; Sehoon Choi; Hyeong Ryul Kim; Yong-Hee Kim; Seung-Il Park
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

5.  [Cardiac surgery in underlying chronic pulmonary disease. Prognostic implications and efficient preoperative evaluation].

Authors:  D Fistera; H Steveling; A Koch; H Teschler
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

6.  [Acute on chronic respiratory failure in interstitial pneumonias].

Authors:  M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-08-16       Impact factor: 0.840

7.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.

Authors:  Kerri Johannson; Harold R Collard
Journal:  Curr Respir Care Rep       Date:  2013-12

Review 8.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Tomoo Kishaba
Journal:  Eurasian J Med       Date:  2017-10

9.  Critical exacerbation of idiopathic pulmonary fibrosis after transcatheter aortic valve implantation: Need for multidisciplinary care beyond "heart team".

Authors:  Yoichiro Sugizaki; Shumpei Mori; Yuichi Nagamatsu; Tomomi Akita; Akira Nagasawa; Takayoshi Toba; Masatsugu Yamamoto; Tatsuya Nishii; Norihiko Obata; Yoshikatsu Nomura; Hiromasa Otake; Toshiro Shinke; Yutaka Okita; Ken-Ichi Hirata
Journal:  J Cardiol Cases       Date:  2018-08-17

Review 10.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.